Page last updated: 2024-08-17

mannitol and Bronchiectasis

mannitol has been researched along with Bronchiectasis in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.86)	18.2507
2000's	9 (25.71)	29.6817
2010's	22 (62.86)	24.3611
2020's	3 (8.57)	2.80

Authors

Authors	Studies
Altenburg, J; Bilton, D; Boersma, WG; Chalmers, JD; Crichton, ML; De Soyza, A; Laserna, E; Perea, L; Shoemark, A; Sibila, O	1
Abo Leyah, H; Aliberti, S; Chalmers, JD; De Soyza, A; Fardon, TC; Finch, S; Gao, YH; Lonergan, M; Tino, G	1
Bem, RA; Linssen, RSN; Ma, J; Rubin, BK	1
Button, BM; Holland, AE; Le Maitre, C; Romero, L; Steward, R; Tarrant, BJ; Thompson, BR	1
Abisheganaden, JA; Chandrasekaran, R; Chotirmall, SH; Hadinoto, K; Koh, MS; Lim, AYH; Low, TB; Roizman, D; Tan, GL; Teo, J; Tran, TT; Vidaillac, C; Yong, VFL; Yu, H	1
Huang, Z; Jiang, J; Li, G; Lin, L; Liu, C; Lv, L; Quan, G; Wu, C; Wu, Q; Yu, X	1
Anderson, SD; Bilton, D; Charlton, B; Daviskas, E; King, G; Kolbe, J; Milne, D; Stirling, RG; Thompson, BR	1
Rademacher, J; Ringshausen, FC; Welte, T	1
Chan, HK; Crapper, J; Phillips, G; Salama, RO; Traini, D; Young, PM; Zhu, B	1
Crossingham, I; Fowler, SJ; Hart, A; Milan, SJ; Sugumar, K	1
Barker, AF; Bilton, D; Chambers, DC; Charlton, B; De Soyza, A; Dupont, LJ; Fox, HG; O'Dochartaigh, C; Tino, G; van Haren, EH; Vidal, LO; Welte, T; Wu, J	1
Metersky, ML; Yap, VL	1
Grillo, L; Main, E; Rand, S	1
Altenburg, J; Boersma, WG; van der Werf, TS; Wortel, K	1
Chew, JW; Hadinoto, K; Teo, J; Yu, H	1
Aliberti, S; Chalmers, JD; Crichton, M; Davidson, J; De Soyza, A; Dupont, L; Fardon, TC; Finch, S; Goeminne, P; Hill, AT; McDonnell, MJ; Rutherford, R	1
Ilowite, J; Kessler, H; Spiegler, P	1
Anderson, SD; Daviskas, E; Young, IH	1
Metersky, ML	1
Anderson, SD; Daviskas, E; Eberl, S; Young, IH	2
Anderson, SD; Briffa, PJ; Burton, DL; Young, IH	1
Rademacher, J; Welte, T	1
Bendstrup, E; Gjoerup, J; Hilberg, O	1
Rott, HD	1
Ilowite, JS; Nair, GB	1
Daviskas, E; Rubin, BK	1
Anderson, SD; Bye, PT; Daviskas, E; Robinson, M	1
Anderson, SD; Briffa, P; Chan, HK; Cochrane, B; Daviskas, E; Gomes, K; Rubin, BK; Young, IH	1
Greenstone, M; Wills, P	3
Wills, PJ	1
Anderson, SD; Bautovich, G; Chan, HK; Daviskas, E; Eberl, S	1
Anderson, SD; Chan, HK; Daviskas, E; Eberl, S; Young, IH	1

Reviews

16 review(s) available for mannitol and Bronchiectasis

Article	Year
Rational use of mucoactive medications to treat pediatric airway disease. Paediatric respiratory reviews, 2020, Volume: 36 Topics: Adolescent; Adrenal Cortex Hormones; Asthma; Bronchiectasis; Bronchiolitis, Viral; Child; Child, Preschool; Cholinergic Antagonists; Ciliary Motility Disorders; Cystic Fibrosis; Deoxyribonuclease I; Diuretics, Osmotic; Epithelial Sodium Channel Blockers; Expectorants; Humans; Infant; Macrolides; Mannitol; Recombinant Proteins; Respiratory System Agents; Saline Solution, Hypertonic; Severity of Illness Index	2020
Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis. Respirology (Carlton, Vic.), 2017, Volume: 22, Issue:6 Topics: Acetylcysteine; Administration, Inhalation; Bronchiectasis; Chronic Disease; Deoxyribonuclease I; Expectorants; Forced Expiratory Volume; Humans; Lung Diseases; Mannitol; Mesna; Mucociliary Clearance; Quality of Life; Recombinant Proteins; Saline Solution, Hypertonic; Symptom Flare Up; Vital Capacity	2017
Inhaled hyperosmolar agents for bronchiectasis. The Cochrane database of systematic reviews, 2014, May-12, Issue:5 Topics: Anti-Bacterial Agents; Bronchiectasis; Cross-Over Studies; Health Status; Humans; Hypertonic Solutions; Mannitol; Mucociliary Clearance; Osmolar Concentration; Powders; Randomized Controlled Trials as Topic	2014
New therapeutic options for noncystic fibrosis bronchiectasis. Current opinion in infectious diseases, 2015, Volume: 28, Issue:2 Topics: Administration, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchiectasis; Humans; Macrolides; Mannitol; Osmotic Pressure; Saline Solution, Hypertonic; Treatment Outcome	2015
Non-cystic fibrosis bronchiectasis: clinical presentation, diagnosis and treatment, illustrated by data from a Dutch Teaching Hospital. The Netherlands journal of medicine, 2015, Volume: 73, Issue:4 Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Clinical Protocols; Cough; Disease Progression; Diuretics, Osmotic; Humans; Macrolides; Maintenance Chemotherapy; Mannitol; Netherlands; Physical Therapy Modalities; Practice Guidelines as Topic; Respiratory Therapy; Severity of Illness Index; Tomography, X-Ray Computed	2015
Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents. Drugs, 2009, Volume: 69, Issue:4 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Anti-Infective Agents; Anti-Inflammatory Agents; Bronchiectasis; Bronchodilator Agents; Expectorants; Humans; Hypertonic Solutions; Macrolides; Mannitol	2009
New treatment options for bronchiectasis. Therapeutic advances in respiratory disease, 2010, Volume: 4, Issue:2 Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bronchial Spasm; Bronchiectasis; Humans; Macrolides; Mannitol; Saline Solution, Hypertonic	2010
Bronchiectasis--diagnosis and treatment. Deutsches Arzteblatt international, 2011, Volume: 108, Issue:48 Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Humans; Macrolides; Mannitol; Prevalence; Saline Solution, Hypertonic; Treatment Outcome	2011
Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults. Respirology (Carlton, Vic.), 2012, Volume: 17, Issue:6 Topics: Administration, Inhalation; Adult; Bronchiectasis; Humans; Lung; Mannitol; Mucociliary Clearance; Powders; Quality of Life; Randomized Controlled Trials as Topic; Sputum	2012
Pharmacologic agents for mucus clearance in bronchiectasis. Clinics in chest medicine, 2012, Volume: 33, Issue:2 Topics: Administration, Inhalation; Bronchiectasis; Expectorants; Humans; Mannitol; Mucociliary Clearance; Saline Solution, Hypertonic; Treatment Outcome	2012
Effect of inhaled dry powder mannitol on mucus and its clearance. Expert review of respiratory medicine, 2013, Volume: 7, Issue:1 Topics: Administration, Inhalation; Bronchiectasis; Cystic Fibrosis; Dry Powder Inhalers; Humans; Mannitol; Mucociliary Clearance; Mucus; Powders; Treatment Outcome	2013
Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction. Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine, 2002,Fall, Volume: 15, Issue:3 Topics: Bronchiectasis; Cystic Fibrosis; Diuretics, Osmotic; Humans; Mannitol; Mucociliary Clearance; Saline Solution, Hypertonic	2002
Inhaled hyperosmolar agents for bronchiectasis. The Cochrane database of systematic reviews, 2006, Apr-19, Issue:2 Topics: Bronchiectasis; Cross-Over Studies; Health Status; Humans; Hypertonic Solutions; Mannitol; Mucociliary Clearance; Osmolar Concentration; Powders	2006
Inhaled mannitol in cystic fibrosis. Expert opinion on investigational drugs, 2007, Volume: 16, Issue:7 Topics: Administration, Inhalation; Animals; Bronchiectasis; Clinical Trials as Topic; Cystic Fibrosis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drugs, Investigational; Female; Humans; Male; Mannitol; Mice; Mice, Transgenic; Mucociliary Clearance; Sensitivity and Specificity; Treatment Outcome	2007
Inhaled hyperosmolar agents for bronchiectasis. The Cochrane database of systematic reviews, 2001, Issue:2 Topics: Bronchiectasis; Cross-Over Studies; Humans; Hypertonic Solutions; Mannitol; Osmolar Concentration	2001
Inhaled hyperosmolar agents for bronchiectasis. The Cochrane database of systematic reviews, 2002, Issue:1 Topics: Bronchiectasis; Cross-Over Studies; Humans; Hypertonic Solutions; Mannitol; Osmolar Concentration	2002

Trials

9 trial(s) available for mannitol and Bronchiectasis

Article	Year
Heterogeneity of treatment response in bronchiectasis clinical trials. The European respiratory journal, 2022, Volume: 59, Issue:5 Topics: Anti-Bacterial Agents; Azithromycin; Aztreonam; Bronchiectasis; Humans; Mannitol; Quality of Life	2022
Relationship between Symptoms, Exacerbations, and Treatment Response in Bronchiectasis. American journal of respiratory and critical care medicine, 2020, 06-15, Volume: 201, Issue:12 Topics: Administration, Inhalation; Bronchiectasis; Cohort Studies; Cough; Disease Progression; Dry Powder Inhalers; Forced Expiratory Volume; Hospitalization; Humans; Mannitol; Proportional Hazards Models; Pseudomonas Infections; Quality of Life; Scotland	2020
Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis. Chest, 2013, Volume: 144, Issue:1 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Bronchiectasis; Diuretics, Osmotic; Dry Powder Inhalers; Exercise Tolerance; Female; Humans; Lung; Male; Mannitol; Middle Aged; Quality of Life; Respiratory Function Tests; Sputum; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2013
Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Thorax, 2014, Volume: 69, Issue:12 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Expectorants; Female; Forced Expiratory Volume; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Mannitol; Medication Adherence; Middle Aged; Mucociliary Clearance; Quality of Life; Recurrence; Sputum; Treatment Outcome; Young Adult	2014
Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction. Respiratory medicine, 2010, Volume: 104, Issue:11 Topics: Administration, Inhalation; Adult; Aged; Bronchiectasis; Cough; Dose-Response Relationship, Drug; Female; Humans; Male; Mannitol; Middle Aged; Mucociliary Clearance; Mucus; Powders; Spirometry; Treatment Outcome	2010
Sodium cromoglycate and eformoterol attenuate sensitivity and reactivity to inhaled mannitol in subjects with bronchiectasis. Respirology (Carlton, Vic.), 2011, Volume: 16, Issue:1 Topics: Administration, Inhalation; Adult; Aged; Anti-Asthmatic Agents; Bronchial Provocation Tests; Bronchiectasis; Cromolyn Sodium; Cross-Over Studies; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Male; Mannitol; Middle Aged; Oxygen	2011
Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis. The European respiratory journal, 2008, Volume: 31, Issue:4 Topics: Administration, Inhalation; Aged; Bronchiectasis; Cough; Diuretics, Osmotic; Dose-Response Relationship, Drug; Female; Humans; Male; Mannitol; Middle Aged; Mucus	2008
Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. American journal of respiratory and critical care medicine, 1999, Volume: 159, Issue:6 Topics: Administration, Inhalation; Adult; Aerosols; Bronchiectasis; Cough; Dose-Response Relationship, Drug; Female; Humans; Incidence; Male; Mannitol; Middle Aged; Mucociliary Clearance; Powders	1999
The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest, 2001, Volume: 119, Issue:2 Topics: Adult; Aged; Bronchiectasis; Diuretics, Osmotic; Female; Humans; Male; Mannitol; Middle Aged; Mucociliary Clearance	2001

Other Studies

10 other study(ies) available for mannitol and Bronchiectasis

Article	Year
A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart. International journal of pharmaceutics, 2018, Aug-25, Volume: 547, Issue:1-2 Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Case-Control Studies; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Humans; Lactose; Lung; Mannitol; Mucus; Permeability; Pseudomonas aeruginosa	2018
Novel Inhalable Ciprofloxacin Dry Powders for Bronchiectasis Therapy: Mannitol-Silk Fibroin Binary Microparticles with High-Payload and Improved Aerosolized Properties. AAPS PharmSciTech, 2019, Jan-23, Volume: 20, Issue:2 Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Bronchiectasis; Ciprofloxacin; Dry Powder Inhalers; Fibroins; Humans; Mannitol; Particle Size	2019
[Non-cystic fibrosis bronchiectasis [corrected]]. Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:14 Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Diuretics, Osmotic; Humans; Mannitol; Physical Therapy Modalities; Saline Solution, Hypertonic	2014
Multi-breath dry powder inhaler for delivery of cohesive powders in the treatment of bronchiectasis. Drug development and industrial pharmacy, 2015, Volume: 41, Issue:5 Topics: Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Chemistry, Pharmaceutical; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Mannitol; Particle Size; Powders	2015
Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis. Seminars in respiratory and critical care medicine, 2015, Volume: 36, Issue:2 Topics: Bronchiectasis; Cough; Cystic Fibrosis; Deoxyribonuclease I; Humans; Lung; Mannitol; Motor Activity; Mucociliary Clearance; Recombinant Proteins; Respiratory Therapy; Saline Solution, Hypertonic	2015
Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation. International journal of pharmaceutics, 2016, Feb-29, Volume: 499, Issue:1-2 Topics: Aerosols; Anti-Bacterial Agents; Bronchiectasis; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Compounding; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Freeze Drying; Leucine; Mannitol; Nanoparticles; Particle Size; Pseudomonas aeruginosa	2016
The generalizability of bronchiectasis randomized controlled trials: A multicentre cohort study. Respiratory medicine, 2016, Volume: 112 Topics: Aged; Anti-Bacterial Agents; Bronchiectasis; Cohort Studies; Deoxyribonucleases; Diuretics, Osmotic; Female; Humans; Male; Mannitol; Middle Aged; Patient Selection; Randomized Controlled Trials as Topic; Severity of Illness Index	2016
Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis. Respiratory medicine, 2010, Volume: 104, Issue:3 Topics: Administration, Inhalation; Aged; Bronchiectasis; Bronchodilator Agents; Cough; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Middle Aged; Mucociliary Clearance; Sputum; Treatment Outcome	2010
Ejaculate in differential diagnosis. Deutsches Arzteblatt international, 2012, Volume: 109, Issue:17 Topics: Anti-Bacterial Agents; Bronchiectasis; Humans; Macrolides; Mannitol; Saline Solution, Hypertonic	2012
Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum. Respirology (Carlton, Vic.), 2005, Volume: 10, Issue:1 Topics: Administration, Inhalation; Aged; Bronchiectasis; Cough; Elasticity; Expectorants; Female; Follow-Up Studies; Health Status; Humans; Lung; Male; Mannitol; Maximal Midexpiratory Flow Rate; Middle Aged; Mucociliary Clearance; Pulmonary Ventilation; Quality of Life; Sputum; Surface Tension; Viscosity; Wettability	2005